Expert consensus on the role of hematological markers in the early clinical screening of hepatocellular carcinoma

The disease burden of hepatocellular carcinoma (HCC) in China is heavy, and the prognosis is still unfavourable. Therefore, early screening of high-risk groups of HCC through simple methods is the key to achieving early diagnosis and treatment and improving survival. At present, alpha-fetoprotein an...

Full description

Bibliographic Details
Format: Article
Language:English
Published: KeAi Communications Co., Ltd. 2022-06-01
Series:Liver Research
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2542568422000186